Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 222Colorectal Neoplasms 196Rectal Neoplasms 174Stomach Neoplasms 116Pancreatic Neoplasms 100Neoplasm Metastasis 77Colonic Neoplasms 59Neoplasms 50Esophageal Neoplasms 39Triple Negative Breast Neoplasms 38Nasopharyngeal Carcinoma 28Biliary Tract Neoplasms 27Cholangiocarcinoma 23Gallbladder Neoplasms 21Locally Advanced Rectal Cancer 17Carcinoma, Hepatocellular 17Adenocarcinoma 15Gastrointestinal Neoplasms 13Colorectal Cancer Metastatic 13Head and Neck Neoplasms 12Bile Duct Neoplasms 12Adenocarcinoma Of Esophagus 12Esophageal Squamous Cell Carcinoma 11Breast Neoplasms, Male 11Brain Neoplasms 11Liver Neoplasms 10Carcinoma, Renal Cell 10Neuroendocrine Tumors 9Unspecified Adult Solid Tumor, Protocol Specific 8Squamous Cell Carcinoma of Head and Neck 8

Interventions

dostarlimab 2Oxaliplatin 2sintilimab 1irinotecan sucrosofate 1XELOX 1Radiotherapy 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Endoscopic Mucosal Resection 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Rectal Cancer (LARC) × Capecitabine × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡